Alleviation of side effects induced by irinotecan hydrochloride (CPT-11) in rats by intravenous infusion

被引：0
|
作者：
Akinobu Kurita
Shoichi Kado
Norimasa Kaneda
Masaharu Onoue
Shusuke Hashimoto
Teruo Yokokura
机构：
[1] Yakult Central Institute for Microbiological Research,
来源：
Cancer Chemotherapy and Pharmacology | 2003年 / 52卷
关键词：
Irinotecan hydrochloride; CPT-11; SN-38; Myelosuppression; Acute diarrhea; Delayed-onset diarrhea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：349 / 360
页数：11
相关论文
共 50 条
  • [21] The mechanism for the inhibition of acetylcholinesterases by irinotecan (CPT-11)
    Dodds, HM
    Rivory, LP
    MOLECULAR PHARMACOLOGY, 1999, 56 (06) : 1346 - 1353
  • [22] Irinotecan (CPT-11): Pharmacology and clinical applications
    Masuda, N
    Kudoh, S
    Fukuoka, M
    CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1996, 24 (01) : 3 - 26
  • [23] Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats
    Kiyoshi Takasuna
    Takehiro Hagiwara
    Masaaki Hirohashi
    Michiyuki Kato
    Mamoru Nomura
    Eiichi Nagai
    Tsuyoshi Yokoi
    Tetsuya Kamataki
    Cancer Chemotherapy and Pharmacology, 1998, 42 : 280 - 286
  • [24] Inhibition of intestinal microflora β-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats
    Takasuna, K
    Hagiwara, T
    Hirohashi, M
    Kato, M
    Nomura, M
    Nagai, E
    Yokoi, T
    Kamataki, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1998, 42 (04) : 280 - 286
  • [25] Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats
    Chu, XY
    Kato, Y
    Sugiyama, Y
    CANCER RESEARCH, 1997, 57 (10) : 1934 - 1938
  • [26] Irinotecan (CPT-11) Chemotherapy Alters Intestinal Microbiota in Tumour Bearing Rats
    Lin, Xiaoxi B.
    Dieleman, Levinus A.
    Ketabi, Ali
    Bibova, Ilona
    Sawyer, Michael B.
    Xue, Hongyu
    Field, Catherine J.
    Baracos, Vickie E.
    Gaenzle, Michael G.
    PLOS ONE, 2012, 7 (07):
  • [27] Effect of Irinotecan (CPT-11) on fatty acid status in rats with colorectal cancer
    Krishnamurthi, Veena
    Pawlowicz, Megan
    Xue, Hongyu
    Baracos, Vickie
    Clandinin, M. Thomas
    Mazurak, Vera C.
    FASEB JOURNAL, 2008, 22
  • [28] TREATMENT OF ADULT T-CELL LEUKEMIA-LYMPHOMA WITH IRINOTECAN HYDROCHLORIDE (CPT-11)
    TSUDA, H
    TAKATSUKI, K
    OHNO, R
    MASAOKA, T
    OKADA, K
    SHIRAKAWA, S
    OHASHI, Y
    OTA, K
    IMAI, K
    FUKUHARA, S
    HANADA, S
    BRITISH JOURNAL OF CANCER, 1994, 70 (04) : 771 - 774
  • [29] Irinotecan (CPT-11) metabolites in human bile and urine
    Lokiec, F
    duSorbier, BM
    Sanderink, GJ
    CLINICAL CANCER RESEARCH, 1996, 2 (12) : 1943 - 1949
  • [30] Irinotecan (CPT-11) metabolism and disposition in cancer patients
    Sparreboom, A
    de Jonge, MJA
    de Bruijn, P
    Brouwer, E
    Nooter, K
    Loos, WJ
    van Alphen, RJ
    Mathijssen, RHJ
    Stoter, G
    Verweij, J
    CLINICAL CANCER RESEARCH, 1998, 4 (11) : 2747 - 2754
12345